Misuse of Drugs (Controlled Drugs) Order 2001
MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 2001
1989 Revision 1
BR 37/2001
MISUSE OF DRUGS ACT 1972
1972 : 159
MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 2001
The Minister of Health and Family Services, in exercise of the
powers conferred on him by section 3(2) of the Misuse Of Drugs Act
1972, makes the following Order:
Citation
1 This Order may be cited as the Misuse Of Drugs (Controlled
Drugs) Order 2001.
Amendment of Schedule 2 to Act No. 159 of 1972
2 Part I of Schedule 2 to the Misuse of Drugs Act 1972 is deleted
and the new Part I set forth in the Schedule to this Order is substituted.
Commencement
3 This Order commences on 1st August, 2001.
SCHEDULE 2 (paragraph 2)
PART I
1. The following substances and products, namely:-
(a) ACETORPHINE
ACETYLDIHYDROCODEINE
ALFENTANIL
ALLYLPRODINE
ALPHACETYLMETHADOL
MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 2001
2 1989 Revision
ALPHAMEPRODINE
ALPHAMETHADOL
ALPHAPRODINE
ALPRAZOLAM
AMPHETAMINE
ANILERIDINE
ATAMESTANE
BENZETHIDINE
BENZPHETAMINE
BENZYLMORPHINE (3-Benzylmorphine)
BETACETYLMETHADOL
BETAMEPRODINE
BETAMETHADOL
BETAPRODINE
BEZITRAMIDE
BOLANDIOL
BOLASTERONE
BOLAZINE
BOLDENONE
BOLENOL
BOLMANTALATE
BROMAZEPAM
BUFOTENINE
BUPRENORPHINE
CALUUSTERONE
CAMAZEPAM
CANNABINOL DERIVATIVES
CANNABINOL except where contained in Cannabis or
Cannabis resin
CANNABIS AND CANNABIS RESIN
CARFENTANIL
CATHINE
CATHINONE
CHLORDIAZEPOXIDE
CHLORPHENTERMINE
4-CHLOROMETHANDIENONE
CHORIONIC GONADOTROPHIN (HCG) and NON-HUMAN
CHORIONIC GONADOTROPHIN
CLENBUTEROL
CLOBAZAM
CLONAZEPAM
CLONITAZENE
CLORAZEPIC ACID
CLOSTEBOL
MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 2001
1989 Revision 3
CLOTIAZEPAM
CLOXAZOLAM
COCA LEAF
COCAINE
CODEINE
DELORAZEPAM
DESOMORPHINE
DEXTROMORAMIDE
DEXTROPROPOXYPHENE
DIAMORPHINE
DIAMPROMIDE
DIAZEPAM
DIETHYLPROPION
DIETHYLTHIAMBUTENE
DIFENOXIN (1-(3-cyano-3,3-diphenylpropyl)-4-
phenylpiperidine-4-carboxylic acid)
DIHYDROCODEINE
DIHYDROCODEINONE O-CARBOXYMETHYLOXIME
DIHYDROMORPHINE
DIMENOXADOLE
DIMEPHEPTANOL
DIMETHYLTHIAMBUTENE
DIOXAPHETYL BUTYRATE
DIPHENOXYLATE
DIPIPANONE
DROSTANOLONE
DROTEBANOL (3,4-dimethoxy-17-methylmorphinan-
6,14-diol)
ECGONINE and any derivative of ecgonine which is
convertible to ecgonine or to cocaine
ENESTEBOL
EPITIOSTANOL
ESTAZOLAM
ETHCHLORVYNOL
ETHINAMATE
ETHYL LOFLAZEPATE
ETHYLMETHYLTHIAMBUTENE
ETHYLMORPHINE (3-ethylmorphine)
ETHYLOESTRENOL
ETICYCLIDINE
ETONITAZENE
ETORPHINE
ETOXERIDINE
MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 2001
4 1989 Revision
FENCANFAMIN
FENETHYLLINE
FENPROPOREX
FENTANYL
FLUDIAZEPAM
FLUNITRAZEPAM
FLUOXYMESTERONE
FLURAZEPAM
FORMEBOLONE
FURAZABOL
FURETHIDINE
GAMMA-BUTYROLACTONE
GAMMA-HYDROXY-BUTYRATE
GLUTETHIMIDE
HALAZEPAM
HALOXAZOLAM
HYDROCODONE
HYDROMORPHINOL
HYDROMORPHONE
HYDROXYPETHIDINE
ISOMETHADONE
KETAMINE
KETAZOLAM
KETOBEMIDONE
LEFETAMINE
LEVOMETHORPHAN
LEVOMORAMIDE
LEVOPHENACYLMORPHAN
LEVORPHANOL
LOFENTANIL
LOPRAZOLAM
LORAZEPAM
LORMETAZEPAM
LYSERGAMIDE
LYSERGIDE and other N-alkyl derivatives of lysergamide
MAZINDOL
MECLOQUALONE
MEDAZEPAM
MEDOLAZINE
MEFENOREX
MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 2001
1989 Revision 5
MEPHENTERMINE
MEPITIOSTANE
MEPROBAMATE
MESABOLONE
MESCALINE
MESTANOLONE
MESTEROLONE
METAZOCINE
METHADONE
METHADYL ACETATE
METHANDIENONE
METHANDRIOL
METHAQUALONE
METHENOLONE
METHYLAMINOREX
METHYLAMPHETAMINE
METHYLDESORPHINE
METHYLDIHYDROMORPHINE (6-methyldihydromorphine)
METHYLPHENIDATE
METHYLPHENOBARBITONE
METHYLTESTOSTERONE
METHYPRYLONE
METOPON
METRIBOLONE
MIBOLERONE
MIDAZOLAM
MORPHERIDINE
MORPHINE
MORPHINE METHOBROMIDE, morphine n-oxide and other
pentavalent nitrogen morphine derivatives
MYROPHINE
NANDROLONE
N, N-DIETHYLTRYPTAMINE
N, N-DIMETHYLTRYPTAMINE
N-ETHYLAMPHETAMINE
N-HYDROXYTENAMPHETAMINE (N-hydroxy MDA)
NICOCODINE
NICODICODINE (6-nicotinoyldihydrocodeine)
NICOMORPHINE (3,6-dinicotinoylmorphine)
NIMETAZEPAM
NITRAZEPAM
NORACYMETHADOL
NORBOLETONE
NORCLOSTEBOL
NORCODEINE
NORDIAZEPAM
MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 2001
6 1989 Revision
NORETHANDROLONE
NORLEVORPHANOL
NORMETHADONE
NORMORPHINE
NORPIPANONE
OPIUM whether raw, prepared or medicinal
OVANDROTONE
OXABOLONE
OXANDROLONE
OXAZEPAM
OXAZOLAM
OXYCODONE
OXYMESTERONE
OXYMETHLONE
OXYMORPHONE
PEMOLINE
PENTAZOCINE
PETHIDINE
PHENADOXONE
PHENAMPROMIDE
PHENAZOCINE
PHENCYCLIDINE
PHENDIMETRAZINE
PHENMETRAZINE
PHENOMORPHAN
PHENOPERIDINE
PHENTERMINE
PHOLCODINE
PIMINODINE
PINAZEPAM
PIPRADROL
PIRITRAMIDE
POPPY-STRAW and concentrate of poppy-straw
PRASTERONE
PRAZEPAM
PROHEPTAZINE
PROPERIDINE (1-methyl-4-phenylpiperidine-4-carboxylic
acid isopropyl ester)
PROPETANDROL
PROPIRAM
PROPYLHEXEDRINE
PSILOCIN
PYROVALERONE
MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 2001
1989 Revision 7
QUINBOLONE
RACEMETHORPHAN
RACEMORAMIDE
RACEMORPHAN
ROLYCYCLIDINE
ROXIBOLONE
SILANDRONE
SOMATOTROPIN
SOMATREM
SOMATROPIN
STANOLONE
STANOZOLOL
STENBOLONE
SUFENTANIL
TEMAZEPAM
TENOCYCLIDINE
TESTOSTERONE
TETRAZEPAM
THEBACON
THEBAINE
THIOMESTERONE
TILIDATE
TRENBOLONE
TRIAZOLAM
TRIMEPERIDINE
4-BROMO-2,5-DIMETHOXY--METHYLPHENETHYLAMINE
4-CYANO-2-DIMETHYLAMINO-4,4-DIPHENYLBUTANE
4-CYANO-1-METHYL-4-PHENYLPIPERDINE
2,5 -DIMETHOXY-,4-DIMETHYLPHENETHYLAMINE
2-METHYL-3-MORPHOLINO-1,1-
DIPHENYLPROPANECARBOXYLIC ACID
1-METHYL-4-PHENYLPIPERIDINE-4-CARBOXYLIC ACID
4-PHENYLPIPERIDINE-4-CARBOXYLIC ACID ETHYL
ESTER (norpethidine)
(b) any 5,5 disubstituted barbituric acid;
(c) any compound (not being a compound for the time being
specified in sub-paragraph (a) above) structurally derived
from tryptamine or from a ring-hydroxy tryptamine by
substitution at the nitrogen atom of the sidechain with one
or more alkyl substituents but no other substituent;
MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 2001
8 1989 Revision
(d) any compound (not being methoxyphenamine or a
compound for the time being specified in sub-paragraph (a)
above) structurally derived from phenethylamine, an N-
alkylphenethylamine, -methylphenethylamine, and N-
Alkyl -methylphenethylamine, or an N-alkyl -
ethylphenethylamine by substitution in the ring to any
extent with alkyl, alkoxy, alkylenedioxy or halide
substituents, whether or not further substituted in the ring
by one or more other univalent substituents.
(e) any compound (not being a compound for the time being
specified in sub-paragraph (a) above) structurally derived
from fentanyl by modification in any of the following ways,
that is to say —
(i) by replacement of the phenyl portion of the
phenethyl group by any heteromonocycle whether or
not further substituted in the heterocycle;
(ii) by substitution in the phenethyl group with alkyl,
alkenyl, alkoxy, hydroxy, halogeno, haloalkyl, amino
or nitro groups;
(iii) by substitution in the piperidine ring with alkyl or
alkenyl groups;
(iv) by substitution in the aniline ring with alkyl, alkoxy
alkylenedioxy, halogeno or haloalkyl groups;
(v) by substitution at the 4-position of the piperidine
ring with any alkoxycarbonyl or alkoxyalkyl or
acyloxy group;
(vi) by replacement of the N-propionyl group by another
acyl group;
(f) any compound (not being a compound for the time being
specified in sub-paragraph (a) above) structurally derived
from pethidine by modification in any of the following ways,
that is to say —
(i) by replacement of the 1-methyl group by an acyl,
alkyl whether or not unsaturated, benzyl or
phenethyl group, whether or not further substituted;
(ii) by substitution in the piperidine ring with alkyl or
alkenyl groups or with a propano bridge, whether or
not further substituted;
MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 2001
1989 Revision 9
(iii) by substitution in the 4-phenyl ring with alkyl,
alkoxy, aryloxy, halogeno or haloalkyl groups;
(iv) by replacement of the 4-ethoxycarbonyl by any other
alkoxycarbonyl or any alkoxyalkyl or acyloxy group;
(v) by formation of a N-oxide or of a quaternary base;
(g) [any drug falling within the following generic definition:],
that is to say, any compound (not being Trilostane or a
compound for the time being specified in sub-paragraph
(a)) structurally derived from 17-hydroxyandrostan-3-one
or from 17-hydroxyestran-3-one by modification in any of
the following ways —
(i) by further substitution at position 17 by a methyl or
ethyl group;
(ii) by substitution to any extent at one or more of
positions 1, 2, 4, 6, 7, 9, 11 or 16 but at no other
positions;
(iii) by unsaturation in the carbocyclic ring system to
any extent, provided that there are no more than
two ethylenic bonds in any one carbocyclic ring;
(iv) by fusion of ring A with a heterocyclic system.
2. Any stereoisomeric form of a substance for the time being
specified in paragraph 1 not being dextromethorphan or
dextrorphan.
3. Any ester or ether or a substance for the time being specified in
paragraph 1 or 2.
4. Any substance which is an ester or ether (or, where more than
one hydroxyl function is available, both an ester and an ether) or
a substance specified in the paragraphs 1(f)(i) to (iv).
5. Any salt of a substance for the time being specified in any of
paragraphs 1 to 3.
6. Any preparation or other product containing a substance or
product for the time being specified in any of paragraphs 1 to 4.
MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 2001
10 1989 Revision
Made this 1st day of August, 2001
Minister of Health and Family Services
